The U.S. FDA is launching a program under which its commissioner can issue vouchers to companies he finds are aligned with ...

(Reuters) -The U.S. Food and Drug Administration on Tuesday announced that it will issue a new priority review voucher to ...

The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump’s second term.

The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...

Our investigation exposed a little-known practice inside the FDA that allowed more than 150 drugs or their ingredients into ...

Kraft Heinz will be pulling certain artificial dyes from its U.S. products starting in 2027 and will no longer roll out new ...

Garadacimab-gxii is the first and only treatment that targets factor XIIa (FXIIa) for the prophylactic prevention of reditary ...

Kraft Heinz plans to remove all artificial dyes from its U.S. products by 2027 amid the Trump administration's push to remove ...

"Transparency is important to us at Wildtype." Wildtype is the third lab-grown meat producer to receive full government ...

Rein Therapeutics has paused patient enrollment and dosing in a mid-stage trial of its lung disease drug in the U.S. after ...

KalVista Pharmaceuticals' said on Friday that the U.S. Food and Drug Administration had extended the review of its drug for a ...